Varicella Vaccine Live Attenuated IP

Trade Name: Zuvicella
Available Strength : 0.5 ML
Available Combination : The active ingredient is: Live Attenuated Varicella Virus (OKA strain). Each 0.5 mL dose of reconstituted vaccine contains: ?2000 PFU (plaque forming units) of varicella virus (OKA strain).
Packing : 1x0.5ml
Pack Insert/Leaflet : YES
Therapeutic use : Zuvicella Vaccine is indicated for active immunization for prevention of chickenpox in individuals 12 months of age and older. It is generally given as an injection under the skin or into the muscle of the upper arm in two doses.
Capacity : 1000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.